Robert Hoepner

2.2k total citations
96 papers, 1.1k citations indexed

About

Robert Hoepner is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Robert Hoepner has authored 96 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pathology and Forensic Medicine, 32 papers in Neurology and 31 papers in Oncology. Recurrent topics in Robert Hoepner's work include Multiple Sclerosis Research Studies (49 papers), Polyomavirus and related diseases (21 papers) and Peripheral Neuropathies and Disorders (16 papers). Robert Hoepner is often cited by papers focused on Multiple Sclerosis Research Studies (49 papers), Polyomavirus and related diseases (21 papers) and Peripheral Neuropathies and Disorders (16 papers). Robert Hoepner collaborates with scholars based in Switzerland, Germany and United States. Robert Hoepner's co-authors include Andrew Chan, Ralf Gold, Anke Salmen, Ingo Kleiter, Carsten Lukas, Simon Faissner, Ilya Ayzenberg, Kerstin Hellwig, Ortwin Adams and Gisa Ellrichmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Robert Hoepner

89 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Hoepner 543 324 292 178 169 96 1.1k
Marc Pawlitzki 434 0.8× 357 1.1× 150 0.5× 150 0.8× 94 0.6× 81 1.1k
Kurt‐Wolfram Sühs 574 1.1× 462 1.4× 197 0.7× 366 2.1× 152 0.9× 77 1.6k
Gabriel Bsteh 1.1k 1.9× 603 1.9× 251 0.9× 145 0.8× 134 0.8× 138 1.6k
Anke Salmen 546 1.0× 236 0.7× 146 0.5× 107 0.6× 54 0.3× 91 898
Jan‐Patrick Stellmann 579 1.1× 232 0.7× 111 0.4× 153 0.9× 39 0.2× 49 1.1k
Carolina Ionete 495 0.9× 251 0.8× 151 0.5× 491 2.8× 70 0.4× 51 1.3k
Aaron Boster 925 1.7× 405 1.3× 239 0.8× 306 1.7× 35 0.2× 44 1.4k
Helle Bach Søndergaard 758 1.4× 155 0.5× 277 0.9× 500 2.8× 75 0.4× 76 1.7k
Bardia Nourbakhsh 877 1.6× 357 1.1× 208 0.7× 268 1.5× 108 0.6× 58 1.5k
J Mikol 310 0.6× 402 1.2× 354 1.2× 592 3.3× 190 1.1× 73 1.8k

Countries citing papers authored by Robert Hoepner

Since Specialization
Citations

This map shows the geographic impact of Robert Hoepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hoepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hoepner more than expected).

Fields of papers citing papers by Robert Hoepner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Hoepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hoepner. The network helps show where Robert Hoepner may publish in the future.

Co-authorship network of co-authors of Robert Hoepner

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Hoepner. A scholar is included among the top collaborators of Robert Hoepner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Hoepner. Robert Hoepner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Franca, Piotr Radojewski, Roland Wiest, et al.. (2024). Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events. Therapeutic Advances in Neurological Disorders. 17. 4233518941–4233518941. 2 indexed citations
2.
Hoepner, Robert, et al.. (2024). Sex‐ and age‐related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials. European Journal of Neurology. 31(10). e16396–e16396. 1 indexed citations
3.
4.
Linington, Christopher, Andrew Chan, Jeffrey L. Bennett, et al.. (2023). Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. Multiple Sclerosis and Related Disorders. 78. 104892–104892. 4 indexed citations
5.
Salmen, Anke, et al.. (2022). Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature. European Journal of Neurology. 30(4). 1135–1147. 5 indexed citations
6.
Rebsamen, Michael, Piotr Radojewski, Andrew Chan, et al.. (2022). Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy. CNS Neuroscience & Therapeutics. 29(2). 538–543. 4 indexed citations
7.
Hoepner, Robert, Andreas G. F. Hoepner, Simon Jung, et al.. (2022). Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System. Therapeutic Advances in Neurological Disorders. 15. 4213410471–4213410471. 4 indexed citations
8.
Hoepner, Robert, Stephen L. Leib, Franziska Suter‐Riniker, et al.. (2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines. 10(6). 922–922. 2 indexed citations
9.
Hoepner, Robert, Mathias Abegg, Christopher Linington, et al.. (2022). Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis. Neurology Neuroimmunology & Neuroinflammation. 9(2). 18 indexed citations
10.
Weber, Lea, et al.. (2022). Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study. CNS Neuroscience & Therapeutics. 28(12). 1953–1963. 15 indexed citations
11.
Salmen, Anke, Robert Hoepner, Lutz Achtnichts, et al.. (2022). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. SHILAP Revista de lepidopterología. 7(1). 2–2. 2 indexed citations
12.
Chan, Andrew, Christian P. Kamm, Chloé Sieber, et al.. (2022). The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing. JMIR Medical Informatics. 10(11). e37945–e37945. 2 indexed citations
13.
Wagner, Franca, et al.. (2022). Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple Sclerosis Journal. 29(1). 63–73. 11 indexed citations
14.
Suter‐Riniker, Franziska, Stephen L. Leib, Andrew Chan, et al.. (2021). Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic Advances in Neurological Disorders. 14. 4203297729–4203297729. 4 indexed citations
15.
Chaloulos-Iakovidis, Panagiotis, Franca Wagner, Lea Weber, et al.. (2021). Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study. Therapeutic Advances in Neurological Disorders. 14. 4203311752–4203311752. 4 indexed citations
16.
Hoepner, Robert, et al.. (2020). Immunomodulatory treatment in postural tachycardia syndrome: A case series. European Journal of Neurology. 28(5). 1692–1697. 21 indexed citations
17.
Salmen, Anke, et al.. (2020). c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells. 9(10). 2154–2154. 14 indexed citations
18.
Wiest, Roland, Franca Wagner, Mathias Abegg, et al.. (2020). Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS Neuroscience & Therapeutics. 27(4). 426–438. 8 indexed citations
19.
Jalowiec, Katarzyna Aleksandra, et al.. (2019). Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis. Transfusion Medicine and Hemotherapy. 46(6). 417–422. 7 indexed citations
20.
Salmen, Anke, Christian P. Kamm, Leonidas Stefanis, et al.. (2018). Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study. CNS Neuroscience & Therapeutics. 25(4). 527–531. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Pawlitzki Breakdown of academic impact, for papers by Kurt‐Wolfram Sühs Breakdown of academic impact, for papers by Gabriel Bsteh Breakdown of academic impact, for papers by Anke Salmen Breakdown of academic impact, for papers by Jan‐Patrick Stellmann Breakdown of academic impact, for papers by Carolina Ionete Breakdown of academic impact, for papers by Aaron Boster Breakdown of academic impact, for papers by Helle Bach Søndergaard Breakdown of academic impact, for papers by Bardia Nourbakhsh Breakdown of academic impact, for papers by J Mikol
Rankless by CCL
2026